from www.streetinsider.com:
>>Soleil Securities is reiterating its Buy rating on shares of Accuray (Nasdaq: ARAY) and is rasing its price target from $10 to $11 as it believes that the company will benefit from Alliance Imaging (NYSE: AIQ) acquirering U.S. Radiosurgery's CyberKnife business.
Alliance obtained 7 additional CyberKnife centers which brings that company's total to 13 and makes Alliance the leading company in CyberKnife systems.
Wednesday, April 13, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment